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Abstract
Background: Health-related quality of life (HRQoL) is impaired in patients with stable angina but patients often
present with other forms of chest pain. The aim of this study was to compare the pre-diagnostic HRQoL in patients
with suspected coronary artery disease (CAD) according to angina type, gender, and presence of obstructive CAD.
Methods: From the pilot study for the European DISCHARGE trial, we analysed data from 24 sites including 1263 patients
(45.9% women, 61.1 ± 11.3 years) who were clinically referred for invasive coronary angiography (ICA; 617 patients) or
coronary computed tomography angiography (CTA; 646 patients). Prior to the procedures, patients completed HRQoL
questionnaires: the Short Form (SF)-12v2, the EuroQoL (EQ-5D-3 L) and the Hospital Anxiety and Depression Scale.
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Results: Fifty-five percent of ICA and 35% of CTA patients had typical angina, 23 and 33% had atypical angina, 18 and 28%
had non-anginal chest discomfort and 5 and 5% had other chest discomfort, respectively. Patients with typical angina had
the poorest physical functioning compared to the other angina groups (SF-12 physical component score; 41.2 ± 8.8, 43.3 ±
9.1, 46.2 ± 9.0, 46.4 ± 11.4, respectively, all age and gender-adjusted p< 0.01), and highest anxiety levels (8.3 ± 4.1, 7.5 ± 4.1,
6.5 ± 4.0, 4.7 ± 4.5, respectively, all adjusted p< 0.01). On all other measures, patients with typical or atypical angina had lower
HRQoL compared to the two other groups (all adjusted p< 0.05). HRQoL did not differ between patients with and without
obstructive CAD while women had worse HRQoL compared with men, irrespective of age and angina type.
Conclusions: Prior to a diagnostic procedure for stable chest pain, HRQoL is associated with chest pain characteristics, but
not with obstructive CAD, and is significantly lower in women.
Trial registration: Clinicaltrials.gov, NCT02400229.
Keywords: Chest pain, Angina, Coronary artery disease, Computed tomography angiography, Invasive coronary
angiography, Health-related quality of life
Background
About 20 million patients present annually in Europe
with recent onset stable chest pain [1]. Patients with
stable chest pain are frequently referred for diagnostic
evaluation for coronary artery disease (CAD). A high
percentage of patients referred for invasive coronary
angiography (ICA) have no obstructive CAD, [2, 3] but
even with mild CAD or normal coronary arteries, pa-
tients are still at increased risk for future major adverse
cardiovascular events and all-cause mortality [4, 5]. After
the exclusion of obstructive CAD, many patients con-
tinue to experience cardiac symptoms such as palpita-
tions, dyspnoea and chest pain, which negatively impact
their health-related quality of life (HRQoL) [6]. HRQoL
refers to how people perceive the impact of health con-
ditions or symptoms on their quality of life, in the do-
mains of physical, emotional and social well-being as
well as functional capacities in everyday life.
Compared to the general population of adults without
CAD, HRQoL is decreased in adults with CAD, with the
most pronounced differences in self-rated physical func-
tioning and self-rated overall health [7]. Patients with
stable angina pectoris also have lower HRQoL in com-
parison to the general population [8, 9].
However, not all patients referred for a cardiac
diagnostic procedure have typical angina pectoris;
atypical angina as well as non-anginal chest discom-
fort may also prompt a referral for diagnostic evalu-
ation of CAD [3, 10–12]. To our knowledge, no study
to date has assessed how these different presentations
of chest pain or discomfort relate to HRQoL.
In the present study, we analyse whether there is a re-
lationship between different presentations of chest dis-
comfort and HRQoL in patients referred for diagnostic
ICA or computed tomography (CTA). We further test
whether pre-diagnostic HRQoL differs between patients
with and without obstructive CAD, and male and female
patients.
Methods
Design, participants and procedure
This study is part of the pilot study of the multicenter
DISCHARGE trial (www.dischargetrial.eu; EC-GA
603266), a pragmatic randomized controlled trial at 25
European clinical sites in 16 countries which assesses
the comparative effectiveness of ICA and CTA in chest
pain patients with a low-to-intermediate likelihood for
CAD [13]. One of the purposes of the pilot study was to
test the logistic feasibility of a pre-diagnostic assessment
of several validated HRQoL measures. The DISCHARGE
pilot study was non-randomised and the protocol re-
quested that each site include at least 60 patients with
suspected CAD who were routinely referred for diagnos-
tic evaluation (30 CTA and 30 ICA). Referred patients
had to have stable chest pain and be at least 30 years of
age. Exclusion criteria were not having a sinus rhythm,
being pregnant or depending on haemodialysis.
Patients were approached for study participation in
the clinics upon their scheduled visit for ICA or CTA.
Dependent on local requirements for data acquisition,
written and/or oral informed consent was given by all
patients participating in the DISCHARGE pilot study. A
study nurse interviewed patients to assess the criteria for
angina classification. Patients then completed the
HRQoL measures on paper. After that, they underwent
their scheduled diagnostic procedure in routine care.
All data was stored anonymously. The study was ap-
proved by the ethics committee of the Charité- Universi-
tätsmedizin Berlin (EA1/294/13) and by the German
Federal Office for Radiation Protection (Z5–2246/2–
2014-001).
Measures
Health-related quality of life
Short form (SF)-12v2 The SF-12v2 is a generic measure
of health status which encompasses an eight-scale profile
of functional health and well-being (physical functioning,
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physical health-related role limitations, bodily pain, gen-
eral health, vitality, social functioning, emotional health-
related role limitations and mental health) [14]. The eight
domains are aggregated in a physical component sum-
mary score (PCS) and mental component summary score
(MCS). Scores were transformed to t-scores [14]. We ap-
plied the standard scoring algorithm (based on the SF-
12v2 2009 U.S. general population normative sample) be-
cause country-specific algorithms are only available for
some, but not all countries in DISCHARGE.
EuroQoL (EQ-5D-3 L) The EQ-5D-3 L [15] assesses
current HRQoL in five dimensions: mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression,
each of which can take one of three responses (no prob-
lems/some or moderate problems/extreme problems).
We calculated the percentages of patient groups with
some/moderate or extreme problems in each domain.
Further, health states can be presented along the five di-
mensions, e.g. health state 11212 represents a patient who
indicates some problems (=2) on the usual activities and
anxiety/depression dimensions and no problems (=1) on
the other dimensions. These health states can be con-
verted to a single index value using available EQ-5D-3 L
value sets. We used the value set appropriate for all Euro-
pean countries (study type VAS) [15].
Additionally, the EuroQol includes a visual analogue
scale (VAS) on which participants rate how good or bad
their own health is today, on a scale from 0 (worst imagin-
able health state) to 100 (best imaginable health state).
Hospital anxiety and depression scale The HADS as-
sesses the presence and severity of symptoms of anxiety
and depression and was originally developed as a screen-
ing tool for affective disorders in medical patients [16].
The depression and anxiety subscales each contain seven
questions with scores from 0 to 3. Total scores for each
subscale thus range from 0 to 21, with higher scores in-
dicating worse anxiety / depression.
Angina classification and diagnosis of obstructive coronary
artery disease
A study nurse interviewed patients to assess the spe-
cific nature of their angina. They were then classified
according to one of four angina categories [11]: 1)
typical angina pectoris (fulfilling the three criteria a)
retrosternal chest discomfort, b) chest discomfort pre-
cipitated by exertion, and c) prompt relief [30s – 10
min] of chest discomfort by rest or nitroglycerin) 2)
atypical angina pectoris (two out of three criteria for
typical angina pectoris), 3) non-anginal chest discom-
fort (one out of three criteria for typical angina pec-
toris) and 4) other chest discomfort (none of the
criteria for typical angina pectoris).
Obstructive CAD was defined as the presence of at
least one coronary artery > 50% diameter stenosis diag-
nosed by either CTA or ICA. For cases in whom an ICA
was performed after CTA, the ICA result was selected
for final diagnosis.
Statistical analyses
Two-level analyses were performed with angina classifica-
tion, diagnostic outcome (positive versus negative for CAD)
and gender as independent factors and age as covariate. The
upper level of the analysis consisted of the participating sites,
the lower level of the individual patients. Linear random
intercept models were used to account for possible correla-
tions arising from the two-level structure. Missing values
were imputed using Rubin’s method of multiple imputation
with m= 20 samples (imputation method: predictive mean
matching). Since only between 1.1 and 3.3% of the values
were missing we calculated means, standard deviations and
errors from the original sample and used multiple imput-
ation only for the confirmatory part (P-values) of the analysis.
Intra class correlation coefficients for all measures ranged be-
tween 0.05 and 0.08 indicating that site effects are small. The
two-sided level of significance was α= 0.05. Since no primary
and secondary endpoints were defined for the pilot study, we
did not adjust the level of significance for multiple testing.
For graphic display of all measures in one diagram,
measures were standardized such that the minimum ob-
servation of all measures corresponds to 0 and the max-
imum observation to 100.
All statistical analyses were performed using the statis-
tical programming language R version 3.3.1. For the
two-level and multiple imputation analyses the functions
lme and mice from the R packages nlme version 3.1–131
and mice version 2.46.0, respectively, were used.
Results
Characteristics of the study sample
Between April 2014 and July 2017, 25 sites included a
total of 1523 patients. Of these, 60 patients were ex-
cluded post-hoc and 200 patients had to be excluded
from the present analyses due to insufficient or missing
HRQoL data or inconclusive / invalid diagnostic result
(Fig. 1). Characteristics of the remaining analysis sample
from 24 sites (n = 1263) are displayed in Table 1. Of
these, 617 underwent ICA, 570 had a CT only and 76
had a CT and a subsequent ICA. About 45% of patients
had typical angina pectoris, 28% atypical angina pectoris,
23% non-anginal chest discomfort, and 5% other chest
discomfort. Overall, 69% of patients were found to not
have obstructive CAD (no obstructive CAD was found
in 56%, 77% 82% and 83% among patients with typical
angina pectoris, atypical angina pectoris, non-anginal
and other chest pain, respectively).
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Health-related quality of life, angina classification and
diagnostic outcome
Figure 2 shows (standardized) differences in HRQoL mea-
sures by angina group and by CAD group. For the Figure,
scores for the EurQol and the HADS were recoded so that
higher values indicate higher HRQoL on all measures.
The mean scores and results of pairwise comparisons (ad-
justed for age and gender) are displayed in the respective
Table 2. Patients with typical angina had lower SF-12
physical functioning scores and higher HADS anxiety
levels compared to the three other angina groups. On all
other measures, patients with typical or atypical angina
were similar and had lower scores compared to the two
other groups. Patients with non-anginal and other chest
discomfort did not differ in their HRQoL on any measure.
Fourty-eight % of the entire sample (55%, 50%, 38%,
18% among typical angina, atypical angina, non-anginal
chest discomfort and other chest discomfort patients)
had a HADS anxiety score of > = 8, commonly used as a
cut-off for clinical anxiety. Because the anxiety levels
were overall very high, we further tested whether pa-
tients differed in their anxiety according to the original
diagnostic procedure they had been scheduled for. Mean
(SD) anxiety scores were slightly higher in patients
scheduled for ICA (7.7 ± 4.2) in comparison to those
of patients scheduled for CT (7.4 ± 4.3; age and gen-
der- adjusted p < 0.01). Importantly, controlling for
the scheduled diagnostic procedure did not attenuate
the anxiety differences between the chest pain groups
which all remained significant.
Fig. 1 Patient flow-chart
Table 1 Characteristics of the Study Sample
Total Sample
(n = 1263)
Age, years 61.1 ± 11.3
Men 683 (54.1%)
Angina Classification
Typical Angina Pectoris 569 (45.1%)
Atypical Angina Pectoris 352 (27.9%)
Non-anginal chest discomfort 284 (22.5%)
Other chest discomfort 58 (4.6%)
Obstructive CAD based upon results of diagnostic procedure 389 (30.8%)
Values are presented as mean ± SD or n (%)
CAD coronary artery disease
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With and without adjustment for age and gender, there
were no significant HRQoL differences between patients
with and without obstructive CAD. Only a non-significant
trend towards a lower SF-12 physical functioning score
was observed for patients with CAD (Table 2).
Figure 3 depicts the percentage of patients with some
or moderate / extreme problems in mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression
according to the EQ-5D-3 L. Again, patients with and
without a diagnosis of CAD did not differ on any of
these dimensions.
Gender differences in health-related quality of life
All measures indicate significantly poorer HRQoL for
women (see Fig. 4). Mean (SD) values for the SF-12
physical component summary score and the SF-12
Fig. 2 Health-related quality of life in (a) angina groups and (b) patients with and without CAD. For graphic display, measures were standardized
such that the minimum observation of all measures corresponds to 0 and the maximum observation to 100. CAD, Coronary artery disease; HADS,
Hospital anxiety and depression scale; VAS, visual analogue scale
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mental component summary score were 41.8 (9.3) and
44.1 (9.7) for women and 44.2 (9.2) and 47.0 (9.8) for
men (p = 0.001 and p < 0.001). For EQ-5D utilities, the
mean (SD) score was 0.66 (0.21) for women and
0.71 (0.20) for men (p < 0.001). On the VAS, the
mean score was 64.5 (19.3) for women and 67.7
(19.3) for men (p = 0.010). Mean HADS depression
and anxiety scores were 6.39 (4.06) and 8.23 (4.32)
for women and 5.47 (3.81) and 6.91 (4.03) for men
(both p < 0.001). After adjusting for age and angina
classification, all gender differences remained sig-
nificant (all p < 0.01).
Table 2 Health-related quality of life measures
Total
sample
Gender Angina Classification Diagnostic Outcome
Men Women p Typical
Angina
Pectoris
Atypical
Angina
Pectoris
Non-anginal
chest
discomfort
Other
chest
discomfort
p* ObstructiveCAD No
obstructive
CAD
p
SF-12 Physical
Health
43.1
(9.3)
44.2
(9.2)
41.8
(9.3)
0.001 41.2
(8.8)abc
43.3 (9.1)ade 46.2 (9.0)bd 46.4
(11.4)ce
<
0.001
41.9 (8.9) 43.7 (9.4) 0.072
SF-12 Mental
Health
45.7
(9.8)
47.0
(9.8)
44.1
(9.7)
<
0.001
44.5 (9.5)ab 45.1 (9.9)cd 47.6 (10.1)ace 51.4
(8.7)bde
<
0.001
45.6 (10.0) 45.7 (9.8) 0.117
EQ-5D-3 L
Visual
Analogue Scale
66.3
(18.8)
67.7
(18.3)
64.5
(19.3)
0.010 64.0
(18.1)ab
65.6
(19.4)cd
69.6 (18.8)ace 76.6
(16.8)bde
<
0.001
64.1 (18.3) 67.2 (19.0) 0.111
EQ-5D-3 L
Utility Score
0.69
(0.21)
0.71
(0.20)
0.66
(0.21)
<
0.001
0.65
(0.21)ab
0.68
(0.20)cd
0.74 (0.20)ac 0.79
(0.22)bd
<
0.001
0.67 (0.20) 0.69 (0.21) 0.230
HADS
Depression
5.9
(3.95)
5.5
(3.8)
6.4 (4.1) <
0.001
6.5 (4.0)ab 6.1 (3.7)cd 4.8 (3.8)ac 4.6 (4.5)bd <
0.001
6.0 (4.0) 5.8 (4.0) 0.380
HADS Anxiety 7.5
(4.21)
6.9
(4.0)
8.2 (4.3) <
0.001
8.3 (4.1)a 7.5 (4.1)a 6.5 (4.0)a 4.6 (4.5)a <
0.001
7.3 (4.1) 7.6 (4.2) 0.861
Unadjusted values are presented as mean ± SD. p-values are based upon multiple imputation analyses and adjusted for age and gender where appropriate.
Possible site effects were accounted for by mixed model analysis
* Pairwise comparisons: angina classification groups with a common superscript differ significantly (p < 0.05). After applying a Bonferroni correction, some of the
comparisons between patients with other or non-anginal chest discomfort and atypical angina pectoris do not reach statistical significance
Measures (possible range in parenthesis): SF-12 Physical and Mental Health (0–100), EQ-5D-3 L Visual Analogue Scale (0–100), EQ-5D-3 L Utility Score (−0.0734–1)
and HADS Depression and Anxiety (0–21)
Fig. 3 Percentage of patients with some or moderate / extreme problems in EuroQol problem dimensions. Problem dimensions from the
EuroQol (EQ-5D-3 L). Groups refer to: 1 = Typical angina pectoris, 2 = Atypical angina pectoris, 3 = Non-anginal chest discomfort and 4 = Other
chest discomfort
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Sensitivity analysis
Analyses comparing patients with and without obstruct-
ive CAD were repeated in the subsample of patients who
had typical angina pectoris. In this subsample, there
were also no differences in HRQoL between patients
with and without an eventual diagnosis of CAD (all p-
values > 0.3, data not shown).
Discussion
This study included 1263 patients from 24 European
sites which were referred for elective ICA or CTA.
There were significant differences in pre-diagnostic
HRQoL according to patients’ chest pain characteristics.
Adjusting for age and gender, patients with typical and
atypical angina pectoris had worse quality of life in com-
parison to patients with non-anginal chest pain and
other chest discomfort. These differences were observed
across the different functional and emotional aspects of
HRQoL and also across the different measures we
employed here, confirming their good discriminative val-
idity for different presentations of chest pain.
In comparison to patients with atypical angina, typical
angina patients had worse self-rated physical functioning
and higher levels of anxiety, but no HRQoL differences
between these two angina groups were observed on the
other measures. Thus, the SF-12 physical functioning
and the HADS anxiety score appear to have a somewhat
greater discriminatory power compared to the EuroQol
utility score, which is a multidimensional conglomerate
of several physical and emotional states.
Minimal clinically important differences (MCID) in
these measures have not been assessed for patients with
chest discomfort. Conventionally, for the SF-12, a 2-point
difference is often assumed a MCID, and differences be-
tween typical angina patients and the other chest pain
groups exceeded this difference in both the mental and
physical health component score of the SF-12.
Comparisons of the HRQoL scores in the present sam-
ple with other patient samples should be made with cau-
tion due to sample differences in age, gender and clinical
characteristics.
Patients in our sample had similar (<= 1 point differ-
ence) pre-diagnostic physical functioning and mental
health component scores on the SF-12 compared to a
sample of 4146 patients with stable angina from the Scot-
tish COmputed Tomography of the HEART (SCOT-
HEART) trial, which compared standard care for angina
patients with standard care plus CTA [17]. However,
SCOT-HEART did not differentiate between different
chest pain presentations and also included angina patients
with known CAD. In the Cresent trial, [18] which com-
pared the effectiveness and safety of cardiac CTA and
functional testing in 350 patients (> 50% with typical chest
pain), overall health ratings with the EuroQol VAS were
comparable to the ones in our sample. In the recent Pro-
spective Multicenter Imaging Study for Evaluation of
Chest Pain (PROMISE) trial, [19] which randomized
Fig. 4 Summary of health-related quality of life differences between women and men. For graphic display, measures were standardized such that
the minimum observation of all measures corresponds to 0 and the maximum observation to 100. HADS, Hospital anxiety and depression scale;
VAS, visual analogue scale
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patients to either standard functional testing or CTA, the
pre-diagnostic EuroQol VAS scores were higher in com-
parison to our sample. However, only 11% of patients in-
cluded in the PROMISE trial had typical angina pectoris.
In comparison to the HRQoL of 8745 stable coronary
heart disease patients with clinical events > 6months
ago in the Euroaspire study, [20] the total sample of the
DISCHARGE pilot study patients had similar EuroQol
utility and VAS scores, similar HADS depression scores,
but substantially lower SF-12 mental health scores (4
point difference) and higher anxiety (1.6 point differ-
ence). In all these comparisons, HRQoL scores for the
subgroups of patients with typical angina pectoris in our
study fall substantially below the HRQoL of the other
samples, indicating a high burden associated with this
type of chest pain.
Notably, almost half of our entire sample had a HADS
anxiety score > =8, the suggested cut-off [16] for prob-
able clinical anxiety. Heightened anxiety prior to a diag-
nostic procedure has been described before [21] and
could be attributed to the uncertainty of the origin of
the chest pain / discomfort and the fear associated with
heart disease.
Patients with and those without obstructive CAD did
not differ in their pre-diagnostic HRQoL, not even in pa-
tients with typical angina pectoris. Thus, underlying ob-
structive cardiac disease cannot explain the HRQoL
differences between angina groups. This is in accordance
with findings from a Canadian study with 1009 patients
referred for elective coronary angiography [22]. Com-
pared with population norms, patients with and without
CAD had high anxiety levels and lower HRQoL; the two
groups did not differ on most HRQoL measures with
the exception of lower self-rated physical functioning in
patients with CAD. However, no information on the ini-
tial chest pain characteristics were given in the Canadian
sample and the CAD outcomes included mild CAD
which we did not assess in our study.
There were substantial gender differences in HRQoL:
women had consistently worse quality of life on all mea-
sures. Gender differences in HRQoL are well docu-
mented across a variety of chronic diseases. Women are
at greater risk for having clinical and subthreshold de-
pression and anxiety and perceive greater physical and
social limitations in their daily lives. In a study with 123
patients with stable CAD and angina pectoris, men and
women described their chest pain in a similar manner,
but women reported significantly higher physical limita-
tions due to angina pain [23].
It should be noted that HRQoL is also a prognostic
factor in cardiac disease. In CAD patients, perceived
physical limitations in everyday life were associated with
increased mortality and admission for acute coronary
syndrome across one year [24]. Depression and anxiety
are also prognostic factors for adverse cardiac outcomes
and mortality in patients with established CAD [25, 26]
and also in patients with stable angina [27, 28]. Whether
patients’ HRQoL prior to or after receiving a diagnosis
of CAD has an impact on the subsequent treatment rec-
ommendations by physicians (e.g., conservative treat-
ment vs. invasive procedures) remains to be studied.
Strengths and limitations
In this multisite, multinational study, the range of patients
with different presentation of chest pain reflects the clinical
reality of diagnostic referrals. The pre-intervention assess-
ments ensured that the HRQoL assessment was not influ-
enced by patients’ knowledge of their actual diagnosis. One
limitation was that only obstructive CAD was diagnosed.
There may well have been HRQoL differences between pa-
tients with no CAD, mild (non-obstructive) CAD and ob-
structive CAD. We did not assess severity and frequency of
chest discomfort, which may account for some of the
HRQoL differences between the chest pain groups. The
EuroQol utility values, for example, have been shown to co-
vary with clinically important differences in angina severity,
angina frequency and exertion [29, 30]. We did not include
healthy controls from each of the sites. However, the main
focus was to analyse whether different presentations of chest
pain were associated with HRQoL and all measures were
able to discriminate between chest pain groups.
Conclusions
More than half of the stable chest pain patients referred
for diagnostic evaluation did not have typical angina
pectoris. Our study showed that differences in chest pain
presentation are associated with significant difference in
HRQoL. Typical angina patients reported worse physical
functioning and higher anxiety compared to patients
with atypical, non-anginal or other chest discomfort, to
a clinically meaningful extent. Patients with typical or
atypical angina significantly differed from the two other
groups in anxiety and depression, overall physical func-
tioning, mobility, overall pain and daily functioning.
Overall, anxiety levels were close to or above a clinical
cut-off. Women consistently reported substantially
worse HRQoL compared to men. Notably, patients with
versus those without obstructive CAD did not differ in
their HRQoL, suggesting that the association between
symptoms and HRQoL is driven by symptoms and not
by cardiac disease. Further studies should assess how
diagnostic evaluation for CAD impacts the HRQoL in
patients with different presentations of chest pain, with
and without confirmed CAD.
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